103 related articles for article (PubMed ID: 17379138)
1. When an inhibitor promotes activity.
Bouvier M
Chem Biol; 2007 Mar; 14(3):241-2. PubMed ID: 17379138
[No Abstract] [Full Text] [Related]
2. Design, synthesis, and biological evaluation of enantiomeric beta-N-acetylhexosaminidase inhibitors LABNAc and DABNAc as potential agents against Tay-Sachs and Sandhoff disease.
Rountree JS; Butters TD; Wormald MR; Boomkamp SD; Dwek RA; Asano N; Ikeda K; Evinson EL; Nash RJ; Fleet GW
ChemMedChem; 2009 Mar; 4(3):378-92. PubMed ID: 19145603
[TBL] [Abstract][Full Text] [Related]
3. High-throughput screening for human lysosomal beta-N-Acetyl hexosaminidase inhibitors acting as pharmacological chaperones.
Tropak MB; Blanchard JE; Withers SG; Brown ED; Mahuran D
Chem Biol; 2007 Feb; 14(2):153-64. PubMed ID: 17317569
[TBL] [Abstract][Full Text] [Related]
4. Late-onset Tay-Sachs disease.
Neudorfer O; Kolodny EH
Isr Med Assoc J; 2004 Feb; 6(2):107-11. PubMed ID: 14986470
[No Abstract] [Full Text] [Related]
5. [Magnetic resonance imaging in Tay-Sachs disease].
Ozawa H; Sugai K; Sasaki S
No To Shinkei; 1995 Aug; 47(8):800-1. PubMed ID: 7546928
[No Abstract] [Full Text] [Related]
6. Tay-Sachs disease: the search for the enzymatic defect.
Brady RO
Adv Genet; 2001; 44():51-60. PubMed ID: 11596998
[No Abstract] [Full Text] [Related]
7. A novel HEXA mutation [1393G>A (D465N)] in a Mexican Tay-Sachs disease patient.
Alvarez-Rodríguez A; Triggs-Raine B; Barros-Núñez P; Lozano CM
Hum Mutat; 2001 May; 17(5):437. PubMed ID: 11317368
[No Abstract] [Full Text] [Related]
8. A case of the B1 variant of GM2-gangliosidosis.
Gray RG; Green A; Rabb L; Broadhead DM; Besley GT
J Inherit Metab Dis; 1990; 13(3):280-2. PubMed ID: 2146441
[No Abstract] [Full Text] [Related]
9. Potent GH20 N-Acetyl-β-d-hexosaminidase Inhibitors: N-Substituted 3-acetamido-4-amino-5-hydroxymethyl-cyclopentanediols.
Weber P; Nasseri SA; Pabst BM; Torvisco A; Müller P; Paschke E; Tschernutter M; Windischhofer W; Withers SG; Wrodnigg TM; Stütz AE
Molecules; 2018 Mar; 23(3):. PubMed ID: 29558439
[TBL] [Abstract][Full Text] [Related]
10. Genetic errors and enzyme replacement strategies.
Brady RO
Res Publ Assoc Res Nerv Ment Dis; 1983; 60():181-93. PubMed ID: 6130585
[No Abstract] [Full Text] [Related]
11. N-acetyl-beta-D-hexosaminidase from Trichomonas vaginalis: substrate specificity and activity of inhibitors.
Sanon A; Tournaire-Arellano C; El Hage SY; Bories C; Caujolle R; Loiseau PM
Biomed Pharmacother; 2005 Jun; 59(5):245-8. PubMed ID: 15890491
[TBL] [Abstract][Full Text] [Related]
12. β-N-acetylhexosaminidase: what's in a name…?
Slámová K; Bojarová P; Petrásková L; Kren V
Biotechnol Adv; 2010; 28(6):682-93. PubMed ID: 20438826
[TBL] [Abstract][Full Text] [Related]
13. Gaining insight into the inhibition of glycoside hydrolase family 20 exo-β-N-acetylhexosaminidases using a structural approach.
Sumida T; Stubbs KA; Ito M; Yokoyama S
Org Biomol Chem; 2012 Apr; 10(13):2607-12. PubMed ID: 22367352
[TBL] [Abstract][Full Text] [Related]
14. A selective inhibitor Gal-PUGNAc of human lysosomal beta-hexosaminidases modulates levels of the ganglioside GM2 in neuroblastoma cells.
Stubbs KA; Macauley MS; Vocadlo DJ
Angew Chem Int Ed Engl; 2009; 48(7):1300-3. PubMed ID: 19130519
[TBL] [Abstract][Full Text] [Related]
15. Tay-Sachs disease.
Fernandes Filho JA; Shapiro BE
Arch Neurol; 2004 Sep; 61(9):1466-8. PubMed ID: 15364698
[No Abstract] [Full Text] [Related]
16. Inhibition of O-GlcNAcase by a gluco-configured nagstatin and a PUGNAc-imidazole hybrid inhibitor.
Shanmugasundaram B; Debowski AW; Dennis RJ; Davies GJ; Vocadlo DJ; Vasella A
Chem Commun (Camb); 2006 Nov; (42):4372-4. PubMed ID: 17057847
[TBL] [Abstract][Full Text] [Related]
17. TMG-chitotriomycin as a probe for the prediction of substrate specificity of β-N-acetylhexosaminidases.
Shiota H; Kanzaki H; Hatanaka T; Nitoda T
Carbohydr Res; 2013 Jun; 375():29-34. PubMed ID: 23685037
[TBL] [Abstract][Full Text] [Related]
18. [Tay-Sachs disease].
Itoh T; Miura AB
Ryoikibetsu Shokogun Shirizu; 1998; (22 Pt 3):389-92. PubMed ID: 9851170
[No Abstract] [Full Text] [Related]
19. [Tay-Sachs disease (beta-hexosaminidase alpha-chain deficiency)].
Okada S; Taniike M
Ryoikibetsu Shokogun Shirizu; 1998; (19 Pt 2):394-6. PubMed ID: 9645090
[No Abstract] [Full Text] [Related]
20. Modifying the phenyl group of PUGNAc: reactivity tuning to deliver selective inhibitors for N-acetyl-D-glucosaminidases.
Hattie M; Cekic N; Debowski AW; Vocadlo DJ; Stubbs KA
Org Biomol Chem; 2016 Mar; 14(12):3193-7. PubMed ID: 26924385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
